These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15253477)

  • 41. Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice: a population database study.
    Mathieson L; Severn A; Guthrie B
    Scott Med J; 2013 May; 58(2):69-76. PubMed ID: 23728750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease.
    Oktaviono YH; Kusumawardhani N
    Acta Med Indones; 2020 Jan; 52(1):74-79. PubMed ID: 32291375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison between the effects of lisinopril and losartan on the cougn reflex in anesthetized and awake rabbits.
    Mutolo D; Cinelli E; Bongianni F; Evangelista S; Pantaleo T
    J Physiol Pharmacol; 2013 Apr; 64(2):201-10. PubMed ID: 23756395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of an ACE inhibitor or angiotensin receptor blocker on potassium in CAPD patients.
    Phakdeekitcharoen B; Leelasa-nguan P
    Am J Kidney Dis; 2004 Oct; 44(4):738-46. PubMed ID: 15384026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.
    Antoniou T; Gomes T; Juurlink DN; Loutfy MR; Glazier RH; Mamdani MM
    Arch Intern Med; 2010 Jun; 170(12):1045-9. PubMed ID: 20585070
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: a comparison of lisinopril and losartan.
    Akinboboye OO; Chou RL; Bergmann SR
    J Am Coll Cardiol; 2002 Aug; 40(4):703-9. PubMed ID: 12204500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril.
    Johnson ES; Weinstein JR; Thorp ML; Platt RW; Petrik AF; Yang X; Anderson S; Smith DH
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):266-72. PubMed ID: 20112435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the effect of angiotensin converting enzyme inhibitors and angiotensin receptors blockers on aspirin antiplatelet effect.
    Al-Azzam SI; Alzoubi KH; Khabour OF; Quttina M; Zayadeen R
    Int J Clin Pharmacol Ther; 2016 Feb; 54(2):96-101. PubMed ID: 26709600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and efficacy of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic allograft injury.
    Shah PR; Kute VB; Saboo DS; Goplani KR; Gumber MR; Vanikar AV; Patel HV; Trivedi HL
    Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1128-32. PubMed ID: 22089769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ACE inhibitors, angiotensin II antagonists and cough. The Losartan Cough Study Group.
    Ramsay LE; Yeo WW
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S51-4. PubMed ID: 8583482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors.
    Paster RZ; Snavely DB; Sweet AR; Draper RA; Goldberg AI; Soffer BA; Sweet CS
    Clin Ther; 1998; 20(5):978-89. PubMed ID: 9829449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors.
    Seeman T; Pohl M; Misselwitz J; John U
    Kidney Blood Press Res; 2009; 32(6):440-4. PubMed ID: 20016211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence, Severity, and Outcomes of AKI Associated with Dual Renin-Angiotensin System Blockade.
    Palevsky PM; Zhang JH; Seliger SL; Emanuele N; Fried LF;
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1944-1953. PubMed ID: 27679519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Malignant arrhythmias caused by hyperkalemia: a new area of drug-induced electrolyte abnormalities].
    Tomcsányi J; Somlói M; Arabadzisz H; Horváth L
    Orv Hetil; 2002 Mar; 143(13):663-6. PubMed ID: 11975043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
    Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
    Przegl Lek; 2008; 65(6):312-4. PubMed ID: 18853664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study.
    Lacourcière Y; Lefebvre J; Nakhle G; Faison EP; Snavely DB; Nelson EB
    J Hypertens Suppl; 1994 Jul; 12(2):S49-53. PubMed ID: 7965266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines.
    Gales BJ; Bailey EK; Reed AN; Gales MA
    Ann Pharmacother; 2010 Feb; 44(2):360-6. PubMed ID: 20086184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hyperkalemia during prolonged use of angiotensin II-converting enzyme inhibitors in end-stage renal insufficiency].
    Mooser V; Fellay G; Regamey C
    Schweiz Med Wochenschr; 1992 Dec; 122(50):1927-9. PubMed ID: 1465596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative study assessing the incidence and degree of hyperkalemia in patients on angiotensin-converting enzyme inhibitors versus angiotensin-receptor blockers.
    Salik JR; Golas SB; McCoy TH
    J Hum Hypertens; 2022 May; 36(5):485-487. PubMed ID: 34650213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.